Global Microfluidics Market is Expected to Grow at a CAGR of 21.23% During the Forecast Period (2016-2024)

According to Goldstein Research, Augmentation of R&D investment in pharmaceuticals, life science and rising point of care testing demand, trending lab-on-chip miniature devices, adoption of home health care (POCT),...

According to Goldstein Research, Augmentation of R&D investment in pharmaceuticals, life science and rising point of care testing demand, trending lab-on-chip miniature devices, adoption of home health care (POCT), improving the efficacy of treatment, evaluating drugs and manipulating cells for the treatment of diseases related to heart and cancer, wider insurance infrastructure facilities, precise and accurate results for location of sicknesses, expanding analytic prerequisites, demand for low-volume sample analysis, high-throughput screening methodologies, high return on investment and helps in cost control by minimizing errors tends to drive the market of microfluidic devices. Global microfluidics market outlook also includes product development, technological advancements and investment strategies adopted by major market players in order to expand their business across the globe.

Download Exclusive Sample Report:

Market Segmentation

On the basis of our in-depth analysis, global microfluidics market can be segmented as follows:

By Material Type

  • Silicon-Based Microfluidics
  • Glass-Based Microfluidics
  • Polymer-Based Microfluidics
  • Other Materials-Based (Paper & Ceramics) Microfluidics

By End User

  • Industrial & Environmental
  • Drug Delivery
  • Pharmaceutical & Life Science Research
  • Analysis (Toxicity Screening, Proteomic Analysis & Gene Sequencing)
  • Clinical & Veterinary Diagnostics
  • Point of Care Diagnostics

Based on Geography

  • North America (U.S. & Canada) microfluidics Market {Market Share (%), Market Size(USD Billion)}
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America) microfluidics Market {Market Share (%), Market Size(USD Billion)}
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden &RoE) microfluidics Market {Market Share (%), Market Size(USD Billion)}
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) microfluidics Market {Market Share (%), Market Size(USD Billion)}
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) microfluidics Market {Market Share (%), Market Size(USD Billion)}

Browse Full Report:

Global Biopolymers Market

Polymers play an important role in the chemical industry. Polymers are majorly used in plastic and packaging industry. More than 80% of polymers used globally are derivatives or by-products of the petroleum industry. The Biopolymer Market accounted for USD 3.2 billion in 2015 and expected to reach USD 9.8 billion by the end of forecast period i.e. 2024. Further the market is anticipated to expand at a compound annual growth rate of 11.2% over the forecast period i.e. 2016-2024.

The growing competition in the healthcare industry, coupled with other growth driving factors such as rising demand for genetically modified plants and constant technological advancement in genetic procedures are anticipated drive the global genomics market in near future. The genomics market size is expected to reach USD 24.5 billion by 2025, growing at a compounded annual growth rate of 11.2% during the forecast period 2017-2025.

Digital Genome Market

Global Digital Genome Market is projected to grow at a CAGR of 8.78% during the forecast period (2017-2025). The major driving factor is the adoption of digital genomics to create an intelligent enterprise and capability of digital genomics to take big leaps in digital intelligence-driven business innovation.

Genome Editing/Genome Engineering Market

Global Gene Editing Market is anticipated to grow at a CAGR of 13.2% over the forecast period (2017-2025). Major dynamics boosting the growth of Genome Engineering market are growing government funding and number of genomics projects, high frequency of infectious diseases and cancer, technological innovations, aggregate production of genetically modified crops, and growing application areas of genomics and proteomics.

Metabolomics Market

Global metabolomics market is anticipated to grow at a CAGR of 11.3% over the forecast period 2016-2024 to reach USD 2.1 billion by 2024. Major driving factor for global metabolomics market improving the route from early drug discovery through clinical development as drug discovery is risky and complex process with just 12% of drugs entering the clinical trials ever to make it to the patients.


Global POCT Market accounts for 7-8% share of the global medical devices market. Global medical devices market was valued at USD 315 billion in 2016. The rapid technological development in healthcare devices and reduction in number of skilled healthcare workers, are the major factors driving the growth of global POCT devices market.

Antimicrobial Peptide Market

The main disease areas currently driving the growth of peptide drugs are metabolic diseases and oncology. Anti-microbial peptides are expected to have an opportunistic market in the near future on the back of the introduction of new antibiotics in therapeutics.” Peptide therapeutics market holds 2-3% of share in global pharmaceuticals market. The global Antimicrobial Peptide Market is highly fragmented and valued USD 1.06 billion in 2015. The Global Antimicrobial Peptide Market is anticipated to grow at a CAGR of 7.5% over the forecast period.

Medical Polymer Market

The Medical Polymer Market is valued at USD 12.56billion in 2017, expanding at a CAGR of 8.12% over the forecast period, 2017-2025. Growing home-based healthcare demand, continuously growing pharmaceutical device demand, increasing elderly population and increasing medical need among them along with rapidly spreading chronic diseases, technological advancements, affordable home health care systems along with other alternative treatment methods, and multiple government initiatives which are associated with the cause are anticipated to steer the medical polymers market over the forecast period.

“Global Microfluidics Market Outlook 2024” embodies comprehensive overview of the global microfluidics market. On the basis of our painstaking study, market can be segmented in terms of market segmentation by material type and by end users.

Further, for the detailed analysis, Global Microfluidics Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Agilent Technologies, Bio-Rad Laboratories, Cepheid, Dolomite, Roche, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics Device etc. The major company profiles contain business strategy, major information, regional revenue distribution of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the global microfluidics market trends along with market forecast that will help industry consultants, technology providers, existing companies probing for enlargement opportunities, new players searching potentials and other investors to align their market-centric strategies according to the ongoing and expected trends in the future.

Key questions answered in this global microfluidics market report

  • What is the global microfluidics market Size by 2024 and what would be the expected growth rate of the industry?
  • What is the overall revenue per segment and geography in 2015-16 and what would be the projected revenue per segment and region over the forecast period?
  • What are the microfluidics market trends?
  • What are the factors which are driving this industry?
  • What are the major barriers to microfluidics industry growth?
  • What are the industry opportunities for the existing and entry-level players?
  • What are the recent developments and business strategy of the key players?


Health And Fitness
No Comment

Leave a Reply